A. Christine Argento, MD
VeriStrat® provides a personalized view of each patient's disease state within 72 hours. Test results are predictive of outcomes, independent of ECOG performance status, mutation status, PD-L1 expression, and treatment choice.1,2,3,4,5
VeriStrat Good results indicate a disease state that is more likely to respond to standard of care treatment.
VeriStrat Poor results indicate a chronic inflammatory disease state. These patients may benefit from an alternative treatment strategy2,6, including:
Patients may benefit from novel therapeutic combinations in clinical trials.
“It is recommended that all physicians caring for patients with lung cancer should begin conversations about the patient’s prognosis and goals of care at the time of the diagnosis, and continue these throughout the course of the illness.”
Learn how some of the industry’s leading experts are using Biodesix Lung Reflex® testing in their practice.
Froedtert & the Medical College of Wisconsin
Associate Professor of Medicine
Chest Center of the Carolines at FirstHealth of the Carolinas